跳至主要内容
临床试验/NCT06172491
NCT06172491招募中不适用

Harnessing the Power of Technology to Transform Delirium Severity Measurement in the ICU

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2023年1月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
400
试验地点
1
主要终点
Acceptability of passive digital marker for delirium severity

研究概览

简要总结

The goal of this observational study is to develop a passive digital marker (PDM) for delirium severity and examine its performance in comparison to validated delirium severity tools in ICU patients >50 years of age.

The main questions it aims to answer are:

  • Is the trained convolutional neural network able to reliably measure delirium severity.
  • Is the Passive Digital Marker able to accurately measure delirium severity
  • Is the Passive Digital Marker acceptable and usable by frontline ICU nurse clinicians, patients, and their identified proxies (i.e., caregivers).

Participants will:

  • Study participation involves a video camera recording you 24 hours per day while you are a patient in the Intensive Care Unit (ICU).
  • Study staff will visit you 4 times each day you are in the ICU. You will be asked questions each time they visit to train the digital marker and see differences between assessments and camera data.

详细描述

Bedside cameras will stay up for at least 72 hours (about 3 days), it may be longer if delirium is being experienced and if the patient and or LAR (Legally Authorized Representative) agree to the cameras' continued recording.

The study team will come and ask the patient questions 4 times daily. We will ask questions about their general, mental, and emotional health, their mood and memory. During these visits, the study team will check the alertness of the patient. Alertness will be checked by voice; if they do not respond, we will tap their shoulder gently. We will ask the patient to do activities like remembering words and saying them back, shaking hands, and drawing an object or clock. The study team will administer assessments 4 times daily. Participants will be asked questions about their general, mental, and emotional health, as well as mood and memory. While performing these sessions, the study team will observe the level of awareness. Awareness will be assessed by voice; if they do not respond, we will have to do a gentle tap on their shoulders. The patient will be asked to perform activities such as: remembering words and repeating them back, handshaking, and drawing an object or clock.

In some cases, if the patient's level of awareness alertness is lowered, we will do observation only perform observation assessments. These assessments do not interfere with clinical care. Participation in this study is voluntary.

The study team will continue to follow the patient until discharged from ICU.

The bedside nurse, patient, or family can cover the cameras with a washcloth if needed for privacy. The faces of family and clinicians and the bathing suit areas of patients are blurred before analysis to protect privacy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >50;
  • Estimated length of stay >24 hours in ICU; and
  • Are not admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.

排除标准

  • Admitted for acute alcohol intoxication, drug (prescribed or illicit) overdose or withdrawal.
  • Admitted for acute neuronal injury
  • Unable to communicate with research team due to sensory deficits (aphasic, blind, deaf) or language (does not speak English)

研究组 & 干预措施

No Delirium Severity

Patients who did not experience a level of delirium severity (subsyndromal, mild, moderate, severe)

Delirium Severity

Patients who did experience a level of delirium severity (subsyndromal, mild, moderate, severe)

结局指标

主要结局

Acceptability of passive digital marker for delirium severity

时间窗: 48 months - 60 months

Participants and their identified care partners will be randomized 1:1 to either the Passive Digital Marker for Delirium Severity or usual care. The acceptability of the PDM by clinicians, patients, and care partners will be evaluated. The 4-question tool named Treatment Acceptability and Preference Questionnaire (TAPQ) is scored on a 5-point Likert scale. A higher score indicates higher acceptability.

Delirium Severity

时间窗: 12-48 months

The level of delirium severity will be measured by two types of prospective data collection. The first method is completed by study team members. A trained member of the study team will administer validated assessment tools 4xdaily from enrollment until ICU discharge or death. The Confusion Assessment Method for the Intensive Care Unit Severy Scale (CAM-ICU-7) is the gold standard for delirium severity measurement in the ICU. It is a 7-point scale, with 7 being severe delirium and 0 being no delirium. The second method is a passive digital marker (in development).

Usability of passive digital marker for delirium severity

时间窗: 48 months - 60 months

Participants and their identified care partners will be randomized 1:1 to either the Passive Digital Marker for Delirium Severity or usual care. The usability of the PDM by clinicians, patients, and care partners will be evaluated. The 10-question System Usability Scale is scored on a Likert scale from 1-5. A higher score (0-100 range) indicates higher usability.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Heidi L. Lindroth PhD RN

Heidi L. Lindroth, Ph.D., Nurse Scientist, Assistant Professor of Nursing

Mayo Clinic

研究点 (1)

Loading locations...

相似试验